PF-04531083

Biochem/physiol Actions

PF-04531083 is an orally available, potent and selective sodium channel Nav1.8 blocker. PF-04531083 was designated as a potential treatment of pain.

Legal Information

Pfizer is a registered trademark of Pfizer, Inc.

Sold for research purposes under agreement from Pfizer Inc.

Other Notes

This compound was developed by Pfizer for Ion Channel research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3573680 PF-04531083 white to beige 100 SIGMA-ALDRICH room temp DMSO: 10 mg/mL, clear powder ≥98% (HPLC)
£586.39 (exc VAT) per 25MG
-
+
3573681 PF-04531083 white to beige 100 SIGMA-ALDRICH room temp DMSO: 10 mg/mL, clear powder ≥98% (HPLC)
£156.00 (exc VAT) per 5MG
-
+